SG10201710237PA - Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance - Google Patents
Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose IntoleranceInfo
- Publication number
- SG10201710237PA SG10201710237PA SG10201710237PA SG10201710237PA SG10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA SG 10201710237P A SG10201710237P A SG 10201710237PA
- Authority
- SG
- Singapore
- Prior art keywords
- casein
- beta
- reducing
- lactose intolerance
- preventing symptoms
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title 1
- 108010076119 Caseins Proteins 0.000 title 1
- 201000010538 Lactose Intolerance Diseases 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
- 235000021247 β-casein Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845480P | 2013-07-12 | 2013-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201710237PA true SG10201710237PA (en) | 2018-01-30 |
Family
ID=52280344
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201710237PA SG10201710237PA (en) | 2013-07-12 | 2014-07-10 | Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance |
| SG11201510707YA SG11201510707YA (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510707YA SG11201510707YA (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20160136238A1 (en) |
| EP (2) | EP3542805A1 (en) |
| JP (2) | JP6436592B2 (en) |
| KR (2) | KR102291660B1 (en) |
| CN (3) | CN105431156A (en) |
| AU (2) | AU2014287862B2 (en) |
| BR (1) | BR112016000612B8 (en) |
| CA (2) | CA2917492C (en) |
| CL (1) | CL2016000064A1 (en) |
| DK (1) | DK3019180T3 (en) |
| ES (1) | ES2743194T3 (en) |
| HK (1) | HK1223846A1 (en) |
| IL (2) | IL243366B (en) |
| MX (2) | MX368912B (en) |
| MY (2) | MY172939A (en) |
| NZ (2) | NZ715985A (en) |
| PH (2) | PH12016500032B1 (en) |
| RU (1) | RU2671562C2 (en) |
| SG (2) | SG10201710237PA (en) |
| WO (1) | WO2015005804A1 (en) |
| ZA (1) | ZA201600007B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7137745B2 (en) * | 2015-05-22 | 2022-09-15 | ズィ・エイツー・ミルク・カンパニー・リミテッド | Beta casein A2 and antioxidant capacity |
| WO2017003300A1 (en) * | 2015-06-29 | 2017-01-05 | The A2 Milk Company Limited | A2 beta-casein and viscosity of milk products |
| RU2766194C2 (en) | 2016-03-30 | 2022-02-09 | Зе А2 Милк Компани Лимитед | Beta-casein and cognitive function |
| CA3036494C (en) | 2016-09-30 | 2022-10-18 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
| NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
| WO2021003741A1 (en) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | APPLICATION OF β-CASEIN A2 AND COMPOSITION THEREOF IN PROMOTING PROLIFERATION OF BIFIDOBACTERIUM |
| CN112205476A (en) * | 2019-07-11 | 2021-01-12 | 北京三元食品股份有限公司 | Beta-casein A2 and application of composition thereof in promoting proliferation of bifidobacterium |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE442585T1 (en) | 1994-11-04 | 2009-09-15 | A2 Corp Ltd | SELECTION PROCESS FOR NON-DIABETOGENIC MILK OR MILK PRODUCTS AS WELL AS MILK OR MILK PRODUCTS COVERED HEREIN |
| WO1996036239A1 (en) | 1995-05-16 | 1996-11-21 | Corran Norman Stuart Mclachlan | Food product and process |
| US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
| US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| EP1196047A4 (en) * | 1999-06-29 | 2004-12-22 | New Zealand Milk Inst Ltd | Prophylactic dietary supplement based on milk |
| AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
| US20060280802A1 (en) * | 2002-10-04 | 2006-12-14 | Campbell Julie H | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
| US8524225B2 (en) * | 2003-09-23 | 2013-09-03 | Dsm Ip Assets B.V. | Use of proline specific endoproteases to hydrolyse peptides and proteins |
| CN1899054A (en) * | 2006-07-17 | 2007-01-24 | 颜贻谦 | Method for making sugar-removing milk |
| AU2010233000A1 (en) * | 2009-04-03 | 2011-10-27 | Nestec S.A. | Milk-like beverages |
| US9167824B2 (en) * | 2009-04-15 | 2015-10-27 | Glanbia Nutritionals (Ireland) Limited | Process for the preparation of a reduced lactose milk product |
| DE102010009582A1 (en) * | 2010-02-05 | 2011-08-11 | Vitacare GmbH & Co. KG, 60318 | Agent for use in lactase deficiency and lactose intolerance |
| CN103315063A (en) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | Infant formula milk powder capable of preventing diseases |
| WO2015187795A1 (en) * | 2014-06-03 | 2015-12-10 | Abbott Laboratories | Nutritional compositions comprising a lipophilic active ingredient |
-
2014
- 2014-07-10 BR BR112016000612A patent/BR112016000612B8/en active IP Right Grant
- 2014-07-10 AU AU2014287862A patent/AU2014287862B2/en active Active
- 2014-07-10 KR KR1020207019514A patent/KR102291660B1/en active IP Right Grant
- 2014-07-10 KR KR1020167003267A patent/KR102367941B1/en active IP Right Grant
- 2014-07-10 JP JP2016525322A patent/JP6436592B2/en active Active
- 2014-07-10 CN CN201480039570.XA patent/CN105431156A/en active Pending
- 2014-07-10 MY MYPI2016700051A patent/MY172939A/en unknown
- 2014-07-10 DK DK14823628.4T patent/DK3019180T3/en active
- 2014-07-10 US US14/904,178 patent/US20160136238A1/en not_active Abandoned
- 2014-07-10 ES ES14823628T patent/ES2743194T3/en active Active
- 2014-07-10 CN CN201911100359.5A patent/CN110800803A/en active Pending
- 2014-07-10 RU RU2015156804A patent/RU2671562C2/en active
- 2014-07-10 CN CN202210552915.8A patent/CN114832092A/en active Pending
- 2014-07-10 NZ NZ715985A patent/NZ715985A/en unknown
- 2014-07-10 SG SG10201710237PA patent/SG10201710237PA/en unknown
- 2014-07-10 WO PCT/NZ2014/000141 patent/WO2015005804A1/en active Application Filing
- 2014-07-10 MY MYPI2019006591A patent/MY190309A/en unknown
- 2014-07-10 NZ NZ754642A patent/NZ754642A/en unknown
- 2014-07-10 CA CA2917492A patent/CA2917492C/en active Active
- 2014-07-10 EP EP19169651.7A patent/EP3542805A1/en active Pending
- 2014-07-10 MX MX2016000308A patent/MX368912B/en active IP Right Grant
- 2014-07-10 CA CA3214545A patent/CA3214545A1/en active Pending
- 2014-07-10 EP EP14823628.4A patent/EP3019180B1/en not_active Revoked
- 2014-07-10 SG SG11201510707YA patent/SG11201510707YA/en unknown
-
2015
- 2015-12-27 IL IL243366A patent/IL243366B/en active IP Right Grant
-
2016
- 2016-01-04 ZA ZA2016/00007A patent/ZA201600007B/en unknown
- 2016-01-05 PH PH12016500032A patent/PH12016500032B1/en unknown
- 2016-01-08 MX MX2019012446A patent/MX2019012446A/en unknown
- 2016-01-12 CL CL2016000064A patent/CL2016000064A1/en unknown
- 2016-10-25 HK HK16112270.8A patent/HK1223846A1/en unknown
-
2018
- 2018-08-13 IL IL261143A patent/IL261143B/en active IP Right Grant
- 2018-08-17 JP JP2018153472A patent/JP6990154B2/en active Active
-
2019
- 2019-05-27 AU AU2019203684A patent/AU2019203684B2/en active Active
- 2019-07-03 PH PH12019550112A patent/PH12019550112A1/en unknown
-
2020
- 2020-01-09 US US16/738,792 patent/US20200147173A1/en not_active Abandoned
-
2021
- 2021-12-21 US US17/557,343 patent/US20220175882A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261143B (en) | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance | |
| HK1212582A1 (en) | Temporary valve and valve-filter | |
| PL2968100T3 (en) | Combination of alkylamidothiazoles and preservatives | |
| HK1219421A1 (en) | Combination of kinase inhibitors and uses thereof | |
| IL262302B (en) | Beta-casein a2 and prevention of inflammation of the bowel | |
| HK1221721A1 (en) | Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones bet | |
| SG11201509448WA (en) | Creamer compositions and uses thereof | |
| PL2801293T3 (en) | Seating furniture and cover for same | |
| SG11201505342QA (en) | Valve arrangement and method of operating the same | |
| SG11201507389RA (en) | Integration of hydro-dechlorination and hydro-regeneration | |
| EP3005068A4 (en) | Tap and hold | |
| GB201320992D0 (en) | Complex and uses thereof | |
| HK1220693A1 (en) | Carbohydrate-modified glycoproteins and uses thereof | |
| IL240787A0 (en) | Apolipoprotein mimetics and uses thereof | |
| GB2536524B (en) | Couplings and valves | |
| RS62090B1 (en) | Strain cu1 for the treatment and/or prevention of chronic inflammatory rheumatism | |
| GB201319767D0 (en) | Chromogenic Glucronidase Substrates and Uses | |
| ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
| GB201308639D0 (en) | Biomarkers and uses of thereof | |
| TH1601000120A (en) | Beta-Casein A2 and reducing or preventing symptoms of lactose intolerance | |
| IL227381A0 (en) | Towel and fastener | |
| GB201301698D0 (en) | Towel and method of manufacturing the same | |
| GB201309452D0 (en) | Magnetic fixings and connections | |
| GB201301393D0 (en) | Kiddibidet and pottibidet | |
| GB201312597D0 (en) | TrailerSafe reversing and safety aid |